Drupal.behaviors.print = function(context) {window.print();window.close();}>
McMaster Team Debuts Drug Target-based Method for Predicting Breast Cancer Chemo Response
May 30, 2012
McMaster Team Debuts Drug Target-based Method for Predicting Breast Cancer Chemo Response
By
Molika Ashford
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail
Molika Ashford
.
Related Stories
Axela Partners with OvaGene to Commercialize Ovarian Cancer PGx Test
August 21, 2012 / BioArray News
Post-Neoadjuvant Profiling Approach IDs Breast Cancer Chemo Resistance Mechanism, Suggests Potential Drug Target
June 20, 2012 / Pharmacogenomics Reporter
Q&A: Peter Mac's Ian Campbell on Cancer Genomics, Next-Gen Technologies, and Research in Australia
May 14, 2013 / BioArray News
TCGA Study Shows Molecular Subtypes May Better Stratify Endometrial Cancer Patients than Histology
May 1, 2013 / Pharmacogenomics Reporter
Genomics in the Journals
April 4, 2013 / GenomeWeb Daily News